Paper Details
- Home
- Paper Details
Liposomal-delivery of phosphodiesterase 5 inhibitors augments UT-15C-stimulated ATP release from human erythrocytes.
Author: BowlesElizabeth A, ErcalNuran, FeysDimitri, SpragueRandy S
Original Abstract of the Article :
The use of liposomes to affect targeted delivery of pharmaceutical agents to specific sites may result in the reduction of side effects and an increase in drug efficacy. Since liposomes are delivered intravascularly, erythrocytes, which constitute almost half of the volume of blood, are ideal target...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613235/
データ提供:米国国立医学図書館(NLM)
Liposomes: Delivering the Right Water to the Right Oasis
Pulmonary arterial hypertension (PAH) is a debilitating condition that affects the lungs, making it difficult to breathe. It's like trying to breathe in a desert where the air is thin and suffocating. This study investigates the potential of liposomes, tiny capsules that can carry drugs, to deliver phosphodiesterase 5 (PDE5) inhibitors specifically to red blood cells (erythrocytes).
Erythrocytes are like tiny water carriers in the desert, transporting oxygen throughout the body. In PAH, these cells have difficulty releasing adenosine triphosphate (ATP), a vital molecule for regulating blood vessel diameter. This is like a breakdown in the desert's water distribution system, leading to a lack of flow and hydration. PDE5 inhibitors, like specialized irrigation systems, can help restore ATP release in erythrocytes.
A Targeted Approach: Delivering Water Where It's Needed Most
This study found that liposomal delivery of PDE5 inhibitors significantly increased prostacyclin analog-induced ATP release from erythrocytes. This is like using a targeted irrigation system to deliver water directly to the areas where it's needed most in the desert, ensuring efficient and effective hydration.
A New Frontier in PAH Treatment: Creating a Sustainable Oasis
This research opens up exciting possibilities for treating PAH. By delivering PDE5 inhibitors directly to erythrocytes, we can potentially improve their function and alleviate symptoms of the disease. This is like creating a sustainable oasis in the desert, providing a continuous supply of water and nutrients to support life and growth.
Dr.Camel's Conclusion
This research offers a promising approach to treating PAH, like creating a sustainable oasis in the desert of disease. By delivering PDE5 inhibitors directly to erythrocytes, we can potentially restore their function and create a healthier and more balanced environment for the body.
Date :
- Date Completed n.d.
- Date Revised 2020-09-30
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.